Eric Karas - Net Worth and Insider Trading
Eric Karas Net Worth
The estimated net worth of Eric Karas is at least $87,217 dollars as of 2024-11-05. Eric Karas is the Chief Commercial Officer of ARS Pharmaceuticals Inc and owns about 5,693 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $87,217. Details can be seen in Eric Karas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Karas has not made any transactions after 2024-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Karas
Eric Karas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Karas owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Click here to see the complete history of Eric Karas’s form 4 insider trades.
Insider Ownership Summary of Eric Karas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2022-11-08 | Chief Commercial Officer |
| SPRY | ARS Pharmaceuticals Inc | 2024-09-18 | Chief Commercial Officer |
Eric Karas Latest Holdings Summary
Eric Karas currently owns a total of 1 stock. Eric Karas owns 5,693 shares of ARS Pharmaceuticals Inc (SPRY) as of September 18, 2024, with a value of $87,217.
Latest Holdings of Eric Karas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2024-09-18 | 5,693 | 15.32 | 87,217 |
Holding Weightings of Eric Karas
Eric Karas Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Karas has made a total of 2 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 10,000 shares on September 18, 2024, which brought Eric Karas around $140,000.
Insider Trading History of Eric Karas
- 1
Eric Karas Trading Performance
Eric Karas Ownership Network
Ownership Network List of Eric Karas
Ownership Network Relation of Eric Karas
Eric Karas Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Eric Karas is the Chief Commercial Officer of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
Eric Karas Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Karas. You might contact Eric Karas via mailing address: C/o Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
